ID28854A - Penggunaan benzenasulfonil(tio) urea untuk pengobatan dan pencegahan disfungsi sitem saraf otonom dan penggunaan benzenasulfonil(tio) urea secara berkombinasi dengan penghalang beta-reseptor - Google Patents
Penggunaan benzenasulfonil(tio) urea untuk pengobatan dan pencegahan disfungsi sitem saraf otonom dan penggunaan benzenasulfonil(tio) urea secara berkombinasi dengan penghalang beta-reseptorInfo
- Publication number
- ID28854A ID28854A IDW20010566A ID20010566A ID28854A ID 28854 A ID28854 A ID 28854A ID W20010566 A IDW20010566 A ID W20010566A ID 20010566 A ID20010566 A ID 20010566A ID 28854 A ID28854 A ID 28854A
- Authority
- ID
- Indonesia
- Prior art keywords
- benzenasulfonyl
- iop
- urea
- disfunctions
- combinated
- Prior art date
Links
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 title 2
- 239000004202 carbamide Substances 0.000 title 2
- 230000002567 autonomic effect Effects 0.000 title 1
- 102000012740 beta Adrenergic Receptors Human genes 0.000 title 1
- 108010079452 beta Adrenergic Receptors Proteins 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/40—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
- C07C335/42—Sulfonylthioureas; Sulfonylisothioureas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/52—Y being a hetero atom
- C07C311/54—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
- C07C311/57—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
- C07C311/58—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings having nitrogen atoms of the sulfonylurea groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/54—Silicon-containing compounds
- C08K5/5406—Silicon-containing compounds containing elements other than oxygen or nitrogen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Polymers & Plastics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE1998141534 DE19841534A1 (de) | 1998-09-10 | 1998-09-10 | Verwendung von Benzolsulfonyl(thio)harnstoffen zur Behandlung und Prophylaxe von Dysfunktionen des autonomen Nervensystems und Verwendung von Benzolsulfonyl(thio)harnstoffen in Kombination mit Betarezeptoren-Blockern |
| DE1999101061 DE19901061A1 (de) | 1999-01-14 | 1999-01-14 | Verwendung von Benzolsulfonyl(thio)harnstoffen zur Behandlung von Prophylaxe von Dysfunktionen des autonomen Nervensystems und Verwendung von Benzolsulfonyl(thio)harnstoffen in Kombination mit Betarezeptoren-Blockern |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID28854A true ID28854A (id) | 2001-07-05 |
Family
ID=26048790
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW20010566A ID28854A (id) | 1998-09-10 | 1999-09-02 | Penggunaan benzenasulfonil(tio) urea untuk pengobatan dan pencegahan disfungsi sitem saraf otonom dan penggunaan benzenasulfonil(tio) urea secara berkombinasi dengan penghalang beta-reseptor |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6414030B1 (cs) |
| EP (1) | EP1117409B1 (cs) |
| JP (1) | JP4733268B2 (cs) |
| KR (1) | KR100981592B1 (cs) |
| CN (1) | CN1195524C (cs) |
| AR (1) | AR020411A1 (cs) |
| AT (1) | ATE287718T1 (cs) |
| AU (1) | AU762832B2 (cs) |
| BR (1) | BR9913572A (cs) |
| CA (1) | CA2343009C (cs) |
| CZ (1) | CZ301165B6 (cs) |
| DE (1) | DE69923464T2 (cs) |
| DK (1) | DK1117409T3 (cs) |
| ES (1) | ES2235507T3 (cs) |
| HK (1) | HK1040187B (cs) |
| HU (1) | HU228988B1 (cs) |
| ID (1) | ID28854A (cs) |
| IL (2) | IL141414A0 (cs) |
| MY (1) | MY121798A (cs) |
| NO (1) | NO330215B1 (cs) |
| NZ (1) | NZ510424A (cs) |
| PL (1) | PL194986B1 (cs) |
| PT (1) | PT1117409E (cs) |
| RU (1) | RU2247562C2 (cs) |
| TR (1) | TR200100692T2 (cs) |
| TW (1) | TWI238817B (cs) |
| WO (1) | WO2000015204A2 (cs) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19917233A1 (de) * | 1999-04-16 | 2000-10-19 | Aventis Pharma Gmbh | Kristalline Formen des Natriumsalzes des 5-Chlor-2-methoxy-N-(2-(4-methoxy-3-methylaminothiocarbonylaminosulfonyl-phenyl)-ethyl)- benzamids |
| DE19923086A1 (de) | 1999-05-20 | 2000-11-23 | Aventis Pharma Gmbh | Cinnamoylaminoalkyl-substituierte Benzolsulfonamidderivate, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
| US7620611B1 (en) * | 1999-07-20 | 2009-11-17 | Trilithic, Inc. | Neural networks for ingress monitoring |
| DE10054481A1 (de) | 2000-11-03 | 2002-05-08 | Aventis Pharma Gmbh | Acylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
| DE10054482A1 (de) | 2000-11-03 | 2002-05-08 | Aventis Pharma Gmbh | Heteroarylacryloylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
| DE10129704A1 (de) * | 2001-06-22 | 2003-01-02 | Aventis Pharma Gmbh | Verwendung von Benzolsulfonyl(thio)harnstoffen in der Behandlung des septischen Schocks |
| CN1330630C (zh) * | 2004-03-10 | 2007-08-08 | 中国药科大学 | 新的磺酰(硫)脲衍生物、其制备方法及含有它们的药物组合物 |
| DE102004061017A1 (de) | 2004-12-18 | 2006-06-22 | Sanofi-Aventis Deutschland Gmbh | Piperidinsulfonylharnstoffe und -thioharnstoffe, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
| KR101608702B1 (ko) * | 2007-06-05 | 2016-04-04 | 사노피 | 디(헤테로)아릴사이클로헥산 유도체, 이들의 제조방법, 이들의 용도 및 이들을 포함하는 약제학적 조성물 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1185180B (de) * | 1963-10-19 | 1965-01-14 | Hoechst Ag | Verfahren zur Herstellung von Benzolsulfonylharnstoffen |
| DE1518874C3 (de) * | 1964-10-07 | 1975-03-13 | Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt | Benzolsulfonylharnstoffe und Verfahren zu ihrer Herstellung |
| DE3009047A1 (de) | 1980-03-08 | 1981-09-24 | C.H. Boehringer Sohn, 6507 Ingelheim | Neue l-(acylamino-aryloxy-)2-hydroxy-3-alkinylaminopropane und verfahren zu ihrer herstellung |
| GB8716972D0 (en) * | 1987-07-17 | 1987-08-26 | Pfizer Ltd | Treatment of cardiac arrhythmias |
| EP0612724B1 (de) * | 1993-02-23 | 1996-12-27 | Hoechst Aktiengesellschaft | Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe- Verfahren zu ihrer Herstellung und ihre Verwendung als Pharmazeutika |
| DE19505397A1 (de) | 1995-02-17 | 1996-08-22 | Hoechst Ag | Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| ZA961314B (en) * | 1995-02-21 | 1996-08-27 | Hoechst Ag | Substituted benzenesulfonylureas and -thioreas processes for their preparation their use for the production of pharmaceutical preparations and medicaments containing them |
| JPH11501655A (ja) | 1995-03-10 | 1999-02-09 | ヘキスト・マリオン・ルセル・インコーポレイテツド | ２，３−ジヒドロ−ベンゾフラノール誘導体の新規な製造法 |
| FR2746013B1 (fr) | 1996-03-18 | 1998-05-29 | Sanofi Sa | Utilisation de composes antiarythmiques dans la prevention de la mortalite post infarctus |
-
1999
- 1999-09-02 CZ CZ20010858A patent/CZ301165B6/cs not_active IP Right Cessation
- 1999-09-02 RU RU2001109434/15A patent/RU2247562C2/ru not_active IP Right Cessation
- 1999-09-02 NZ NZ510424A patent/NZ510424A/xx not_active IP Right Cessation
- 1999-09-02 HU HU0103534A patent/HU228988B1/hu not_active IP Right Cessation
- 1999-09-02 ID IDW20010566A patent/ID28854A/id unknown
- 1999-09-02 ES ES99944585T patent/ES2235507T3/es not_active Expired - Lifetime
- 1999-09-02 DK DK99944585T patent/DK1117409T3/da active
- 1999-09-02 PL PL347215A patent/PL194986B1/pl unknown
- 1999-09-02 DE DE69923464T patent/DE69923464T2/de not_active Expired - Lifetime
- 1999-09-02 HK HK02101438.6A patent/HK1040187B/zh not_active IP Right Cessation
- 1999-09-02 CN CNB998107794A patent/CN1195524C/zh not_active Expired - Fee Related
- 1999-09-02 WO PCT/EP1999/006450 patent/WO2000015204A2/en active IP Right Grant
- 1999-09-02 KR KR1020017003067A patent/KR100981592B1/ko not_active Expired - Fee Related
- 1999-09-02 CA CA2343009A patent/CA2343009C/en not_active Expired - Fee Related
- 1999-09-02 AT AT99944585T patent/ATE287718T1/de active
- 1999-09-02 EP EP99944585A patent/EP1117409B1/en not_active Expired - Lifetime
- 1999-09-02 BR BR9913572-8A patent/BR9913572A/pt not_active Application Discontinuation
- 1999-09-02 TR TR2001/00692T patent/TR200100692T2/xx unknown
- 1999-09-02 IL IL14141499A patent/IL141414A0/xx active IP Right Grant
- 1999-09-02 AU AU57444/99A patent/AU762832B2/en not_active Ceased
- 1999-09-02 PT PT99944585T patent/PT1117409E/pt unknown
- 1999-09-02 JP JP2000569788A patent/JP4733268B2/ja not_active Expired - Fee Related
- 1999-09-08 AR ARP990104515A patent/AR020411A1/es not_active Application Discontinuation
- 1999-09-09 MY MYPI99003906A patent/MY121798A/en unknown
- 1999-11-25 TW TW088115446A patent/TWI238817B/zh not_active IP Right Cessation
-
2001
- 2001-02-13 IL IL141414A patent/IL141414A/en not_active IP Right Cessation
- 2001-03-05 NO NO20011117A patent/NO330215B1/no not_active IP Right Cessation
- 2001-11-09 US US09/986,626 patent/US6414030B1/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9712948B1 (pt) | unidade de terapia por fàtons e cabeÇote para tratamento de terapia de fàtons. | |
| DE69726245D1 (de) | Befeuchtungsgerät zur Behandlung von Atemstillstand im Schlaf | |
| FR2720639B1 (fr) | Compositions cosmétiques photoprotectrices et utilisations. | |
| ID22792A (id) | Pigmen titanium dioksida, penyiapan dan penggunaannya | |
| ID21863A (id) | Senyawa kinolin dan kinazolin yangberguna dalam terapi, khususnya dalam pengobatan heperplasia prostatik jinak | |
| ATE331505T1 (de) | Behandlung einer hämoglobinstörung | |
| TR27197A (tr) | Nemlendiriciye sahip sahsi temizlik malzemesi. | |
| TR199501643A2 (tr) | Yünün enzimlerle tedavisi icin yöntem. | |
| FR2759581B1 (fr) | Dispositif de traitement, notamment par moxa, de type acupressure | |
| BR9507010A (pt) | Processos para aumentar o nível de HBF em um indivíduo e para tratar prevenir ou melhorar b-globina ou outros distúrbios relacionados com HBF | |
| ID28854A (id) | Penggunaan benzenasulfonil(tio) urea untuk pengobatan dan pencegahan disfungsi sitem saraf otonom dan penggunaan benzenasulfonil(tio) urea secara berkombinasi dengan penghalang beta-reseptor | |
| ZA965938B (en) | Use of MP52 of MP121 for the treatment and prevention of diseases of the nervous system. | |
| DE3779250D1 (de) | Acrylcopolymere, diese enthaltende hautschutzmittel und ihre anwendung. | |
| DE69732024D1 (de) | Haarbehandlungsmittel | |
| DE59707360D1 (de) | Haarbehandlungsmittel mit langanhaltenden Festigungseigenschaften | |
| SG92610A1 (en) | The use of des-aspartate-angiotensin i as an agent for the treatment and prevention of neointima formation, restenosis, and arteriosclerosis | |
| PT813870E (pt) | Utilizacao da darifenacina para aumentar funcoes cognitivas | |
| FI963264A7 (fi) | Tromboksaani A2-välitteisten sairauksien ennaltaestoon ja hoitoon tarkoitettu aine | |
| DE69830259D1 (de) | Gewebeschutzmittel und der Gebrauch desselben | |
| DE59708501D1 (de) | Haarbehandlungsmittel | |
| FI944687A7 (fi) | Koostumus likinäköisyyden ennaltaehkäisemiseksi ja hoitamiseksi | |
| BR9812491B1 (pt) | método de tratamento de têxteis de spandex, método de tratamento de fibra de spandex, têxtil de spandex tratado e fibra de spandex. | |
| NO996496D0 (no) | (S) 2-metylamino-2-fenyl-n-butyl 3,4,5-trimetoksybenzoat samt anvendelse av denne ved behandling av kronisk smerte | |
| ID17913A (id) | Benzo tio fena dan formulasi yang mengandungnya dan metoda | |
| ES1029384Y (es) | Cortina para baño y/o ducha. |